Marco De Vivo, is the head of the Molecular Modeling and Drug Discovery lab at the Italian Institute of Technology. He is also the Associate Director of the IIT, responsible for Computational Sciences. His research is focused on development of computational methods to achieve an atomic-level comprehension of chemical systems. In 2021, he co-founded IAMA Therapeutics. IAMA Therapeutics is developing small molecules for CNS disorders by selectively inhibiting cation-chloride cotransporters to address atypical brain activity in neurological conditions.
